Nuveen
ACHV icon

Nuveen’s Achieve Life Sciences ACHV Stock Holding History

Nuveen’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
+191,150
New +$911K ﹤0.01% 2833
2025
Q2 		– Sell
-46,668
Closed -$125K – 3275
2025
Q1 		$125K Hold
46,668
– – ﹤0.01% 3197
2024
Q4 		$164K Hold
46,668
– – ﹤0.01% 3234
2024
Q3 		$221K Hold
46,668
– – ﹤0.01% 3208
2024
Q2 		$219K Buy
+46,668
New +$225K ﹤0.01% 3198

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen's ACHV Position: Q2 2026 in Review

Nuveen opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 191,150 shares worth $1.25M. The stake represents ﹤0.01% of the portfolio and ranks #2833 among its holdings. This is a return to the name: Nuveen previously reported a position in ACHV as recently as Q1 2025.

Nuveen first reported a position in ACHV in Q2 2024 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Nuveen held 191,150 shares of Achieve Life Sciences worth $1.25M as of Q2 2026.
  • Achieve Life Sciences was a new Nuveen position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2833 holding.
  • Nuveen first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.